Research News and Research

RSS

Energy drink consumption linked with serious cardiovascular events

Anna Svatikova, M.D., Ph.D., of the Mayo Clinic, Rochester, Minn., and colleagues randomly assigned 25 healthy volunteers (age 18 years or older) to consume a can (480 mL; 16 fl. oz.) of a commercially available energy drink (Rockstar; Rockstar Inc) and placebo drink within 5 minutes, in random order on 2 separate days, maximum 2 weeks apart.

9 Nov 2015

Diabetes drug liraglutide ineffective in patients with advanced heart failure

In an attempt to correct defects in the energy generation that contributes to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure. Despite improvements in blood sugar control, the therapy did not improve the clinical stability or pumping action of the heart in patients with advanced heart failure.

9 Nov 2015

Simple, low risk blood test can detect foetal blood group and genetic conditions in unborn babies

Research into a simple, accurate and low risk blood test that can detect foetal blood group, sex, and genetic conditions in unborn babies has been published in the international scientific journal, Clinical Chemistry.

9 Nov 2015

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

In the coming week, from 16 to 19 November 2015, Düsseldorf will again become the central meeting point of the international health business. Then, for the first time on the new set of dates from Monday to Thursday (previously: Wednesday to Saturday), the world’s largest medical trade fair, MEDICA, and the international leading supplier specialist trade fair, COMPAMED taking place at the same time, are going to start.

9 Nov 2015

St. Michael's Hospital study finds that cholesterol-reducing diet also lowers blood pressure

A diet developed for reducing cholesterol also lowers blood pressure, a St. Michael's Hospital study has found.

9 Nov 2015

NTU Singapore scientists harness dead bacteria to destroy colon tumours cells effectively

Scientists from Nanyang Technological University have successfully used dead bacteria to kill colorectal cancer cells. Harvesting the Clostridium sporogenes bacteria found commonly in soil, the NTU team was able to harness the bacteria in its dead form, and its secretions, to destroy colon tumours cells effectively.

9 Nov 2015

Chromatin Immunoprecipitation validated antibodies launched by Chromatrap

Chromatrap, a business unit of Porvair Sciences Ltd, has announced the launch of its own range of Chromatin Immunoprecipitation (ChIP)-validated antibodies.

From Chromatrap® - Porvair Sciences Ltd 9 Nov 2015

Combatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr Chakravarthy

Inhaled anesthetics are fairly common all over the world for minor and extensive surgical procedures in patients of all age groups. In the olden days when anesthesia was first developed, ether was the first inhaled anesthetic. That has been replaced, with the more recent discoveries of sevoflurane, isoflurane, and desflurane.

9 Nov 2015

Excelitas Technologies® Corp. and Quorum Technologies Present Microscopy Systems for Optogenetics Webinar

Excelitas Technologies® Corp. and Quorum Technologies will present a webinar entitled “How Can I Build a Microscopy System for Optogenetics?” led by featured speakers Kavita Aswani, Ph.D., senior applications scientist for the Life Sciences products at Excelitas Technologies, and Ryan Geil, M.Sc., service manager at Quorum Technologies Inc. The session will be moderated by Photonics Media and takes place on Thursday, November 12 at 1:00 pm (EST).

9 Nov 2015

Researchers develop novel technology for chronic arthritis

Joint inflammation (arthritis) is a common problem in medical practice and can be due to a variety of causes. Many types of inflammatory disorders affecting the joints belong to the diverse group of rheumatic diseases.

6 Nov 2015

Viralytics enters into clinical trial collaboration agreement with MSD

Viralytics Limited announced today that it has entered into a clinical trial collaboration agreement through subsidiaries of Merck & Co., Inc., Kenilworth, New Jersey, U.S.A. (known as MSD outside the United States and Canada) to evaluate the combination of Viralytics' investigational cancer immunotherapy CAVATAK, with MSD's KEYTRUDA, an anti-PD-1 (programmed death receptor-1) therapy.

6 Nov 2015

Mucus plays important role in defending invaders

By licking a wound it heals faster - this is not simply popular belief, but scientifically proven. Our saliva consists of water and mucus, among other things, and the mucus plays an important role. It stimulates white blood cells to build a good defence against invaders, according to a group of researchers at Lund University in Sweden together with colleagues from Copenhagen and Odense in Denmark.

6 Nov 2015

Seven researchers win 2015 Early Career Researcher UK Awards

The UK is a world-leader in breakthrough scientific discoveries, and seven of the early career researchers leading this field have been recognised for their contributions to areas including malaria elimination, securing water supplies for future generations and empowering patients in the management of their own health care.

6 Nov 2015

City of Hope awarded NIH grant to study potential link between environmental factors and breast cancer

The National Institutes of Health has awarded City of Hope a five-year, $4.8 million grant to study the possible role of chemicals in the environment in the development of breast cancer during the menopausal transition in women.

6 Nov 2015

Stem-cell scientists discover new view of how human blood is made

Stem-cell scientists led by Dr. John Dick have discovered a completely new view of how human blood is made, upending conventional dogma from the 1960s.

6 Nov 2015

Utah chemists devise new way to detect DNA damage

University of Utah chemists devised a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders.

6 Nov 2015

Researchers identify seven genetic risk loci involved in atopic march

There's a typical "career" for some allergic people, and it starts very early on the skin: babies develop atopic dermatitis, food allergies may follow, then comes asthma and later on hay fever. A group of scientists led by Ingo Marenholz and Young-Ae Lee at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, working with colleagues from several institutions, has now identified seven genetic risk loci for this course of disease.

6 Nov 2015

Scientists discover small molecule that can block growth of BRCA-deficient cancer cells

Cancer cells with mutations in BRCA1 or BRCA2 genes, which serve a vital role in preserving the integrity of the genetic code, are key targets for cancer therapeutics. Yet, few agents can selectively eliminate cells deficient in BRCA, and none can do so without the risk of inducing drug resistance.

6 Nov 2015

Sleep loss reduces insulin sensitivity, increases diabetes risk

A new study by the University of Colorado shows that the longer people are awake during the time their biological clock is telling them to sleep the worse their sensitivity to insulin, which is a precursor to diabetes.

6 Nov 2015

New tool could help identify patients most likely to benefit from chemoprevention

A team of scientists, led by researchers at University of California, San Diego Moores Cancer Center and The University of Texas MD Anderson Cancer Center, report that a genetic biomarker called loss of heterozygosity or LOH is able to predict which patients with premalignant mouth lesions are at highest risk of developing oral cancer.

6 Nov 2015

Research News and Research

Energy drink consumption linked with serious cardiovascular events

Diabetes drug liraglutide ineffective in patients with advanced heart failure

Simple, low risk blood test can detect foetal blood group and genetic conditions in unborn babies

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

St. Michael's Hospital study finds that cholesterol-reducing diet also lowers blood pressure

NTU Singapore scientists harness dead bacteria to destroy colon tumours cells effectively

Chromatin Immunoprecipitation validated antibodies launched by Chromatrap

Combatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr Chakravarthy

Excelitas Technologies® Corp. and Quorum Technologies Present Microscopy Systems for Optogenetics Webinar

Researchers develop novel technology for chronic arthritis

Viralytics enters into clinical trial collaboration agreement with MSD

Mucus plays important role in defending invaders

Seven researchers win 2015 Early Career Researcher UK Awards

City of Hope awarded NIH grant to study potential link between environmental factors and breast cancer

Stem-cell scientists discover new view of how human blood is made

Utah chemists devise new way to detect DNA damage

Researchers identify seven genetic risk loci involved in atopic march

Scientists discover small molecule that can block growth of BRCA-deficient cancer cells

Sleep loss reduces insulin sensitivity, increases diabetes risk

New tool could help identify patients most likely to benefit from chemoprevention

Industry Focus eBook - Life Science Microscopy (3rd Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (3rd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation